U.S. market Closed. Opens in 5 hours 8 minutes

CRGX | CARGO Therapeutics, Inc. Common Stock Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-31
RevenueN/AN/AN/A
Cost of Revenue3.69M1.44M147.00K
Gross Profit-3.69M-1.44M-147.00K
Operating Expenses93.02M34.77M5.98M
Selling, General & Admin17.23M5.40M1.52M
Research & Development75.79M29.37M4.46M
Other Operating ExpensesN/A-22.00K127.00K
Operating Income-96.71M-34.77M-5.98M
Other Expenses / Income-1.44M-1.24M127.00K
Before Tax Income-98.15M-40.95M-5.85M
Income Tax ExpensesN/A4.92M127.00K
Net Income-98.15M-40.95M-5.85M
Interest Expenses1.60M4.94MN/A
Basic Shares Outstanding41.21M19.23M19.47M
Diluted Shares Outstanding41.21M19.23M19.47M
EBITDA-93.02M-33.35M-5.70M
EBITDA Margin0.00%0.00%0.00%
EBIT-96.54M-31.09M-5.72M
EBIT Margin0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙